scholarly article | Q13442814 |
P356 | DOI | 10.3109/07388551.2010.525498 |
P698 | PubMed publication ID | 21091161 |
P50 | author | Rajan Vyas | Q37830933 |
Rupinder Tewari | Q40274249 | ||
P2093 | author name string | Ankur Gautam | |
P2860 | cites work | Crystal structures of two human pyrophosphorylase isoforms in complexes with UDPGlc(Gal)NAc: role of the alternatively spliced insert in the enzyme oligomeric assembly and active site architecture | Q24535935 |
Autophosphorylation of phosphoglucosamine mutase from Escherichia coli | Q24548987 | ||
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure | Q24644604 | ||
MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli | Q24671787 | ||
The mechanism of sugar phosphate isomerization by glucosamine 6-phosphate synthase | Q24672775 | ||
The femR315 gene from Staphylococcus aureus, the interruption of which results in reduced methicillin resistance, encodes a phosphoglucosamine mutase | Q24678020 | ||
The Helicobacter pylori ureC gene codes for a phosphoglucosamine mutase | Q24678582 | ||
Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli | Q24685902 | ||
Determination of the MurD mechanism through crystallographic analysis of enzyme complexes | Q27618457 | ||
Crystal structure of the bifunctional N-acetylglucosamine 1-phosphate uridyltransferase from Escherichia coli: a paradigm for the related pyrophosphorylase superfamily | Q27619240 | ||
Role of the loop containing residue 115 in the induced-fit mechanism of the bacterial cell wall biosynthetic enzyme MurA | Q27621570 | ||
Structural basis for the interaction of the fluorescence probe 8-anilino-1-naphthalene sulfonate (ANS) with the antibiotic target MurA | Q27622627 | ||
Comparative X-ray analysis of the un-liganded fosfomycin-target murA | Q27622761 | ||
The 1.9 Å crystal structure ofEscherichia coliMurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis | Q27625346 | ||
"Open" structures of MurD: domain movements and structural similarities with folylpolyglutamate synthetase | Q27626831 | ||
Crystal structure of Escherichia coli UDPMurNAc-tripeptide d-alanyl-d-alanine-adding enzyme (MurF) at 2.3 A resolution | Q27628634 | ||
Crystal structure of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase bound to acetyl-coenzyme A reveals a novel active site architecture | Q27628944 | ||
Crystal structure of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-diaminopimelate ligase from Escherichia coli | Q27629001 | ||
Crystal structures of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase, GlmU, in apo form at 2.33 A resolution and in complex with UDP-N-acetylglucosamine and Mg(2+) at 1.96 A resolution | Q27629008 | ||
A structural variation for MurB: X-ray crystal structure of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB) | Q27631486 | ||
Structure of the Escherichia coli GlmU pyrophosphorylase and acetyltransferase active sites | Q27631533 | ||
Channeling of ammonia in glucosamine-6-phosphate synthase | Q27636096 | ||
Crystal structure of the MurG:UDP-GlcNAc complex reveals common structural principles of a superfamily of glycosyltransferases | Q27640334 | ||
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity | Q27640413 | ||
Crystal Structures of Active Fully Assembled Substrate- and Product-Bound Complexes of UDP-N-Acetylmuramic Acid:L-Alanine Ligase (MurC) from Haemophilus influenzae | Q27641592 | ||
A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states | Q27642065 | ||
Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis | Q27644008 | ||
Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis | Q27644055 | ||
Structure of theE. colibifunctional GlmU acetyltransferase active site with substrates and products | Q27644659 | ||
Structure of Escherichia coli UDP-N-acetylmuramoyl:L-alanine ligase (MurC). | Q34586308 | ||
Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase | Q27644808 | ||
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins | Q27646944 | ||
Common alterations in PBP1a from resistant Streptococcus pneumoniae decrease its reactivity toward beta-lactams: structural insights | Q27649202 | ||
Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site | Q27649707 | ||
Crystal structure of UDP-N-acetylglucosamine enolpyruvyl transferase from Haemophilus influenzae in complex with UDP-N-acetylglucosamine and fosfomycin | Q27649770 | ||
Ordering of C-terminal loop and glutaminase domains of glucosamine-6-phosphate synthase promotes sugar ring opening and formation of the ammonia channel | Q27649922 | ||
Crystal Structures of Biapenem and Tebipenem Complexed with Penicillin-Binding Proteins 2X and 1A from Streptococcus pneumoniae | Q27650232 | ||
Structural Analysis of the Contacts Anchoring Moenomycin to Peptidoglycan Glycosyltransferases and Implications for Antibiotic Design | Q27651275 | ||
Identification of dynamic structural motifs involved in peptidoglycan glycosyltransfer | Q27651887 | ||
Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme | Q27652893 | ||
PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity | Q27653322 | ||
Structure ofN-acetylglucosamine-1-phosphate uridyltransferase (GlmU) fromMycobacterium tuberculosisin a cubic space group | Q27655339 | ||
Characterization of the active site of S. aureus monofunctional glycosyltransferase (Mtg) by site-directed mutation and structural analysis of the protein complexed with moenomycin | Q27655367 | ||
Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli | Q27655550 | ||
Evidence of kinetic control of ligand binding and staged product release in MurA (enolpyruvyl UDP-GlcNAc synthase)-catalyzed reactions | Q27658111 | ||
ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation | Q27658363 | ||
A left-handed parallel beta helix in the structure of UDP-N-acetylglucosamine acyltransferase | Q27729303 | ||
(E)-enolbutyryl-UDP-N-acetylglucosamine as a mechanistic probe of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) | Q27732705 | ||
The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls | Q27733360 | ||
Substrate binding is required for assembly of the active conformation of the catalytic site in Ntn amidotransferases: evidence from the 1.8 A crystal structure of the glutaminase domain of glucosamine 6-phosphate synthase | Q27733391 | ||
Crystal structure of UDP-N-acetylglucosamine enolpyruvyltransferase, the target of the antibiotic fosfomycin | Q27733409 | ||
Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin | Q27734363 | ||
X-ray crystal structures of the S229A mutant and wild-type MurB in the presence of the substrate enolpyruvyl-UDP-N-acetylglucosamine at 1.8-A resolution | Q27734743 | ||
Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 A crystal structure of the isomerase domain | Q27765339 | ||
The eukaryotic UDP-N-acetylglucosamine pyrophosphorylases. Gene cloning, protein expression, and catalytic mechanism. | Q27936943 | ||
Formation of the glycan chains in the synthesis of bacterial peptidoglycan | Q28185380 | ||
An evolving hierarchical family classification for glycosyltransferases | Q28190475 | ||
Recent advances in the formation of the bacterial peptidoglycan monomer unit | Q28204307 | ||
Initial stage in peptidoglycan synthesis. IV. Solubilization of phospho-N-acetylmuramyl-pentapeptide translocase | Q28256221 | ||
On the Initial Stage in Peptidoglycan Synthesis. Phospho-N-acetylmuramyl-pentapeptide Translocase (Uridine Monophosphate)* | Q28257596 | ||
Initial membrane reaction in peptidoglycan synthesis. Interaction of lipid with phospho-N-acetylmuramylpentapeptide translocase | Q28326814 | ||
On the specificity of the uridine diphospho-N-acetylmuramyl-alanyl-D-glutamic acid: diamino acid ligase of Bifidobacterium globosum | Q28333474 | ||
Comparison of the UDP-N-acetylmuramate:L-alanine ligase enzymes from Mycobacterium tuberculosis and Mycobacterium leprae | Q28487429 | ||
UDP-N- acetylglucosamine:N -acetylmuramoyl-(pentapeptide) pyrophosphoryl undecaprenol N -acetylglucosamine transferase from Escherichia coli : overproduction, solubilization, and purification | Q57998978 | ||
Invariant Amino Acids in the Mur Peptide Synthetases of Bacterial Peptidoglycan Synthesis and Their Modification by Site-Directed Mutagenesis in the UDP-MurNAc:l-Alanine Ligase from Escherichia coli | Q57998991 | ||
5-Benzylidenethiazolidin-4-ones as Multitarget Inhibitors of Bacterial Mur Ligases | Q58216000 | ||
Three-dimensional structure of adenyl kinase | Q59077251 | ||
MurAA, catalysing the first committed step in peptidoglycan biosynthesis, is a target of Clp-dependent proteolysis in Bacillus subtilis | Q28488903 | ||
Identification of the Pseudomonas aeruginosa glmM gene, encoding phosphoglucosamine mutase | Q28492574 | ||
Peptidoglycan structure and architecture | Q29617858 | ||
Antibacterial resistance worldwide: causes, challenges and responses | Q29620008 | ||
Recent developments in structure-based drug design | Q30652842 | ||
Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan biosynthesis | Q30831090 | ||
Identification of novel inhibitors of Pseudomonas aeruginosa MurC enzyme derived from phage-displayed peptide libraries | Q30890784 | ||
Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme | Q31016009 | ||
Cloning and identification of the Escherichia coli murB DNA sequence, which encodes UDP-N-acetylenolpyruvoylglucosamine reductase | Q31160152 | ||
Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase | Q33202551 | ||
Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen | Q33225062 | ||
Selection of peptide inhibitors against the Pseudomonas aeruginosa MurD cell wall enzyme | Q33235482 | ||
Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens | Q33241226 | ||
A peptide inhibitor of MurA UDP-N-acetylglucosamine enolpyruvyl transferase: the first committed step in peptidoglycan biosynthesis | Q33259874 | ||
A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli | Q33301093 | ||
Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in gram-positive bacteria | Q33601835 | ||
Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2. | Q33714592 | ||
Mycobacterial lipid II is composed of a complex mixture of modified muramyl and peptide moieties linked to decaprenyl phosphate | Q33726863 | ||
Active site restructuring regulates ligand recognition in class A penicillin-binding proteins | Q33756467 | ||
Reaction mechanism of phosphoglucosamine mutase from Escherichia coli. | Q33860899 | ||
Crystal structure of UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase from Escherichia coli | Q33886827 | ||
Beta-lactam antibiotics: from antibiosis to resistance and bacteriology | Q33951933 | ||
Active site comparisons highlight structural similarities between myosin and other P-loop proteins | Q34017547 | ||
Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae | Q34113767 | ||
Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae | Q34140737 | ||
Penicillin-binding proteins 1a and 1b form independent dimers in Escherichia coli. | Q34313500 | ||
3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria | Q34352165 | ||
Characterization of the essential gene glmM encoding phosphoglucosamine mutase in Escherichia coli | Q34370285 | ||
The MurE synthetase from Thermotoga maritima is endowed with an unusual D-lysine adding activity | Q34510574 | ||
Peptidoglycan synthesis in the absence of class A penicillin-binding proteins in Bacillus subtilis | Q34514614 | ||
In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance | Q34514901 | ||
Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance | Q34541598 | ||
The mechanism of action of ramoplanin and enduracidin | Q34553065 | ||
Structure, function and dynamics in the mur family of bacterial cell wall ligases | Q34560768 | ||
Molecular mechanisms of antibacterial multidrug resistance | Q34611916 | ||
Structure, biochemistry and mechanism of action of glycopeptide antibiotics | Q34665729 | ||
Complex lipid requirements for detergent-solubilized phosphoacetylmuramyl-pentapeptide translocase from Micrococcus luteus | Q34718337 | ||
Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities. | Q34722061 | ||
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. | Q34968575 | ||
Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate | Q35021822 | ||
Structure and function of the Mur enzymes: development of novel inhibitors | Q35030909 | ||
Mechanism of action of oritavancin and related glycopeptide antibiotics | Q35066202 | ||
Novel inhibitors of bacterial cell wall synthesis. | Q35565580 | ||
Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin | Q35626765 | ||
A promoter for the first nine genes of the Escherichia coli mra cluster of cell division and cell envelope biosynthesis genes, including ftsI and ftsW. | Q35630514 | ||
Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria | Q35637071 | ||
Glycopeptide antibiotics: from conventional molecules to new derivatives | Q35752864 | ||
Nucleotide sequence of the cell-envelope murG gene of Escherichia coli | Q35839792 | ||
Glycopeptides in clinical development: pharmacological profile and clinical perspectives. | Q35879826 | ||
The final step of peptidoglycan subunit assembly in Escherichia coli occurs in the cytoplasm | Q36087726 | ||
Replacement of diaminopimelic acid by cystathionine or lanthionine in the peptidoglycan of Escherichia coli | Q36109102 | ||
Identification of the glmU gene encoding N-acetylglucosamine-1-phosphate uridyltransferase in Escherichia coli. | Q36122633 | ||
The Escherichia coli mraY gene encoding UDP-N-acetylmuramoyl-pentapeptide: undecaprenyl-phosphate phospho-N-acetylmuramoyl-pentapeptide transferase | Q36129411 | ||
The murG gene of Escherichia coli codes for the UDP-N-acetylglucosamine: N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase involved in the membrane steps of peptidoglycan synthesis | Q36150070 | ||
Incorporation of LL-diaminopimelic acid into peptidoglycan of Escherichia coli mutants lacking diaminopimelate epimerase encoded by dapF. | Q36202185 | ||
Does the cell wall of bacteria remain a viable source of targets for novel antibiotics? | Q36313793 | ||
Lipid intermediates in the biosynthesis of bacterial peptidoglycan | Q36314747 | ||
MraY Inhibitors as Novel Antibacterial Agents | Q36321142 | ||
Syntheses around the transglycosylation step in peptidoglycan biosynthesis | Q36340522 | ||
Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine | Q36379261 | ||
The monofunctional glycosyltransferase of Escherichia coli localizes to the cell division site and interacts with penicillin-binding protein 3, FtsW, and FtsN. | Q36483203 | ||
Fluorescence detection-based functional assay for high-throughput screening for MraY. | Q36492019 | ||
Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. | Q36566587 | ||
Telavancin: a novel lipoglycopeptide for serious gram-positive infections | Q36736356 | ||
DNA sequence of the murE-murD region of Bacillus subtilis 168. | Q36777227 | ||
Serine beta-lactamases and penicillin-binding proteins | Q36784607 | ||
Three-dimensional structure of moenomycin A--a potent inhibitor of penicillin-binding protein 1b. | Q36896175 | ||
Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis | Q36907456 | ||
The biosynthesis of peptidoglycan lipid-linked intermediates | Q37032866 | ||
Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity | Q37051672 | ||
Cytoplasmic steps of peptidoglycan biosynthesis | Q37081699 | ||
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis | Q37081708 | ||
Structural details of the glycosyltransferase step of peptidoglycan assembly. | Q37250015 | ||
Structure-based drug design strategies in medicinal chemistry | Q37597256 | ||
Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release | Q37866109 | ||
Identification of the gonococcal glmU gene encoding the enzyme N-acetylglucosamine 1-phosphate uridyltransferase involved in the synthesis of UDP-GlcNAc | Q38288653 | ||
Evidence of a functional requirement for a carbamoylated lysine residue in MurD, MurE and MurF synthetases as established by chemical rescue experiments | Q38294460 | ||
Characterization of the bifunctional glycosyltransferase/acyltransferase penicillin-binding protein 4 of Listeria monocytogenes | Q38315739 | ||
Identification and characterization of amino acid residues essential for the active site of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) from Staphylococcus aureus | Q38319722 | ||
Kinetic characterization of wild-type and S229A mutant MurB: evidence for the role of Ser 229 as a general acid | Q38349191 | ||
The monofunctional glycosyltransferase of Escherichia coli is a member of a new class of peptidoglycan-synthesising enzymes | Q38353815 | ||
Functional characterization of penicillin-binding protein 1b from Streptococcus pneumoniae | Q38357557 | ||
Acetyltransfer precedes uridylyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional GlmU protein of Escherichia coli | Q38362743 | ||
Identification and characterization of a monofunctional glycosyltransferase from Staphylococcus aureus | Q39526567 | ||
Development of a whole-cell assay for peptidoglycan biosynthesis inhibitors | Q39651496 | ||
The glycosyltransferase domain of penicillin-binding protein 2a from Streptococcus pneumoniae catalyzes the polymerization of murein glycan chains | Q39791499 | ||
Overexpression, purification, and characterization of UDP-N-acetylmuramyl:L-alanine ligase from Escherichia coli | Q39840207 | ||
A putative monofunctional glycosyltransferase is expressed in Ralstonia eutropha | Q39846218 | ||
Identification and characterization of cell wall-cell division gene clusters in pathogenic gram-positive cocci | Q39847107 | ||
Identification of tms-26 as an allele of the gcaD gene, which encodes N-acetylglucosamine 1-phosphate uridyltransferase in Bacillus subtilis | Q39939478 | ||
Phospho-N-acetylmuramoyl-pentapeptide-transferase of Escherichia coli K12 Properties of the membrane-bound and the extracted and partially purified enzyme | Q40196201 | ||
Nucleotide sequence involving murG and murC in the mra gene cluster region of Escherichia coli | Q40518252 | ||
Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria | Q40622160 | ||
Phospho-N-acetyl-muramyl-pentapeptide translocase from Escherichia coli: catalytic role of conserved aspartic acid residues | Q40634273 | ||
Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase | Q40839313 | ||
Structural modifications of glycopeptide antibiotics | Q41287183 | ||
The mechanism of glutamine-dependent amidotransferases | Q41758829 | ||
MurF inhibitors with antibacterial activity: effect on muropeptide levels | Q41823306 | ||
Peptidoglycan biosynthesis by preparations from Bacillus licheniformis: cross-linking of newly synthesized chains to preformed cell wall | Q41836705 | ||
Kinetic characterization of the monofunctional glycosyltransferase from Staphylococcus aureus | Q41855641 | ||
Utility of muropeptide ligase for identification of inhibitors of the cell wall biosynthesis enzyme MurF. | Q41991873 | ||
Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT2 by fumaroyl diaminopropanoic acid derivatives, a novel group of glutamine analogs | Q42207279 | ||
The UDP-N-acetylglucosamine 1-carboxyvinyl-transferase of Enterobacter cloacae. Molecular cloning, sequencing of the gene and overexpression of the enzyme | Q42610701 | ||
Differential antibacterial activity of moenomycin analogues on gram-positive bacteria | Q42636554 | ||
A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). | Q42647502 | ||
A murC gene in Porphyromonas gingivalis 381. | Q42673127 | ||
Studies on the conformational changes in the bacterial cell wall biosynthetic enzyme UDP-N-acetylglucosamine enolpyruvyltransferase (MurA). | Q42680309 | ||
Kinetic and crystallographic studies of Escherichia coli UDP-N-acetylmuramate:L-alanine ligase | Q42845111 | ||
Binding of substrates and modifiers to glucosamine synthetase | Q42922023 | ||
Characterization of L-glutamine:D-fructose-6-phosphate amidotransferase from an extreme thermophile Thermus thermophilus HB8. | Q43024394 | ||
??? | Q27748883 | ||
Structural analysis of an "open" form of PBP1B from Streptococcus pneumoniae. | Q43043712 | ||
Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF. | Q43266886 | ||
Dissection of the bifunctional Escherichia coli N-acetylglucosamine-1-phosphate uridyltransferase enzyme into autonomously functional domains and evidence that trimerization is absolutely required for glucosamine-1-phosphate acetyltransferase activi | Q43510086 | ||
Asparagine 23 and aspartate 305 are essential residues in the active site of UDP-N-acetylglucosamine enolpyruvyl transferase from Enterobacter cloacae | Q43591572 | ||
Inhibitors of the bacterial cell wall biosynthesis enzyme MurC. | Q43621566 | ||
Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis | Q43835367 | ||
Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase | Q43886263 | ||
The Specificity of Enzymes Adding Amino Acids in the Synthesis of the Peptidoglycan Precursors of Corynebacterium poinsettiae and Corynebacterium insidiosum | Q43934957 | ||
The first total synthesis of lipid II: the final monomeric intermediate in bacterial cell wall biosynthesis | Q43944569 | ||
Intrinsic lipid preferences and kinetic mechanism of Escherichia coli MurG. | Q44001893 | ||
Mannopeptimycins, novel antibacterial glycopeptides from Streptomyces hygroscopicus, LL-AC98. | Q44099734 | ||
A kinetic characterization of the glycosyltransferase activity of Eschericia coli PBP1b and development of a continuous fluorescence assay | Q44171772 | ||
A MurG assay which utilises a synthetic analogue of lipid I. | Q44320619 | ||
Discovery of the first antibacterial small molecule inhibitors of MurB. | Q44345485 | ||
Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes | Q44381515 | ||
2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis | Q44508067 | ||
Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II. | Q44514000 | ||
Structures of K(0.05)Na(0.95)NbO3 (50-300 K) and K(0.30)Na(0.70)NbO3 (100-200 K). | Q44948788 | ||
Assembly and stability of nisin-lipid II pores | Q45045783 | ||
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres | Q45243569 | ||
Crystal structure of an Udp-n-acetylmuramate-alanine ligase MurC (TM0231) from Thermotoga maritima at 2.3 A resolution | Q46128390 | ||
4-Alkyl and 4,4'-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesis | Q46465514 | ||
Antibiotic resistance-the problem intensifies | Q46540143 | ||
Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of MurC and MurD as potential antibacterial agents. | Q46765233 | ||
Crystal structure of penicillin-binding protein 1a (PBP1a) reveals a mutational hotspot implicated in beta-lactam resistance in Streptococcus pneumoniae | Q46826792 | ||
Trapping of an acyl-enzyme intermediate in a penicillin-binding protein (PBP)-catalyzed reaction | Q46835683 | ||
Glutamine binding opens the ammonia channel and activates glucosamine-6P synthase | Q46844173 | ||
Staphylococcus aureus MurC participates in L-alanine recognition via histidine 343, a conserved motif in the shallow hydrophobic pocket | Q46847275 | ||
Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening | Q47443022 | ||
Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis | Q47904411 | ||
Cloning and sequencing of Staphylococcus aureus murC, a gene essential for cell wall biosynthesis | Q47909491 | ||
Assembly of the monomer unit of bacterial peptidoglycan | Q48007374 | ||
Conditionally lethal Escherichia coli murein mutants contain point defects that map to regions conserved among murein and folyl poly-gamma-glutamate ligases: identification of a ligase superfamily | Q48049705 | ||
Kinetic mechanism of the Escherichia coli UDPMurNAc-tripeptide D-alanyl-D-alanine-adding enzyme: use of a glutathione S-transferase fusion | Q48056619 | ||
Monofunctional biosynthetic peptidoglycan transglycosylases | Q48066490 | ||
In vitro synthesis of cross-linked murein and its attachment to sacculi by PBP1A from Escherichia coli | Q48086083 | ||
Over-production, purification and properties of the uridine diphosphate N-acetylmuramoyl-L-alanine:D-glutamate ligase from Escherichia coli | Q48194967 | ||
The cell wall and cell division gene cluster in the Mra operon of Pseudomonas aeruginosa: cloning, production, and purification of active enzymes | Q48372742 | ||
Better substrates for bacterial transglycosylases | Q49315804 | ||
Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives | Q50198102 | ||
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening. | Q51816512 | ||
Evaluation of the kinetic mechanism of Escherichia coli uridine diphosphate-N-acetylmuramate:L-alanine ligase. | Q52262082 | ||
Steady-state kinetic mechanism of Escherichia coli UDP-N-acetylenolpyruvylglucosamine reductase. | Q52344239 | ||
2-Aminotetralones: novel inhibitors of MurA and MurZ. | Q52852098 | ||
Crystal structure of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) from Thermus caldophilus. | Q53584302 | ||
Structure-based optimization of MurF inhibitors. | Q53603346 | ||
Structure-activity relationships of novel potent MurF inhibitors. | Q53645851 | ||
Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. | Q53756233 | ||
Topological analysis of the MraY protein catalysing the first membrane step of peptidoglycan synthesis. | Q54072596 | ||
Glucosamine-6-phosphate synthase from Escherichia coli: determination of the mechanism of inactivation by N3-fumaroyl-L-2,3-diaminopropionic derivatives. | Q54325994 | ||
Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases. | Q54419171 | ||
Fluorescent reagents for in vitro studies of lipid-linked steps of bacterial peptidoglycan biosynthesis: derivatives of UDPMurNAc-pentapeptide containing d-cysteine at position 4 or 5. | Q54448724 | ||
Pyrazolidine-3,5-diones and 5-hydroxy-1H-pyrazol-3(2H)-ones, inhibitors of UDP-N-acetylenolpyruvyl glucosamine reductase. | Q54454869 | ||
Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA. | Q54456599 | ||
Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD. | Q54475713 | ||
In vitro murein peptidoglycan synthesis by dimers of the bifunctional transglycosylase-transpeptidase PBP1B from Escherichia coli. | Q54479227 | ||
Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention. | Q54528035 | ||
Affinity labeling of Escherichia coli glucosamine-6-phosphate synthase with a fructose 6-phosphate analog--evidence for proximity between the N-terminal cysteine and the fructose-6-phosphate-binding site. | Q54567628 | ||
Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
Study of the overproduced uridine-diphosphate-N-acetylmuramate:L-alanine ligase from Escherichia coli. | Q54590638 | ||
Structural studies of Escherichia coli UDP-N-acetylmuramate:L-alanine ligase. | Q54593807 | ||
Biochemical evidence for the formation of a covalent acyl-phosphate linkage between UDP-N-acetylmuramate and ATP in the Escherichia coli UDP-N-acetylmuramate:L-alanine ligase-catalyzed reaction. | Q54593810 | ||
The mode of action of bacilysin and anticapsin and biochemical properties of bacilysin-resistant mutants | Q54613752 | ||
Possible involvement of Lys603 from Escherichia coli glucosamine-6-phosphate synthase in the binding of its substrate fructose 6-phosphate. | Q54690765 | ||
Over-production, purification and properties of the uridine-diphosphate-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-2,6-diaminopimelate ligase from Escherichia coli. | Q54704735 | ||
Partial purification and specificity studies of the D-glutamate-adding and D-alanyl-D-alanine-adding enzymes from Escherichia coli K12. | Q54762576 | ||
Glucosamine synthetase from Escherichia coli: purification, properties, and glutamine-utilizing site location. | Q54765865 | ||
Specificity of the uridine-diphosphate-N-acetylmuramyl-L-alanyl-D-glutamate: meso-2,6-diaminopimelate synthetase from Escherichia coli. | Q54790491 | ||
Thermotoga maritima sp. nov. represents a new genus of unique extremely thermophilic eubacteria growing up to 90°C | Q56701239 | ||
Crystallization and Preliminary X-ray Analysis of the Two Domains of Glucosamine-6-phosphate Synthase from Escherichia coli | Q57276497 | ||
Lysine 22 in UDP-N-Acetylglucosamine Enolpyruvyl Transferase fromEnterobacter cloacaeIs Crucial for Enzymatic Activity and the Formation of Covalent Adducts with the Substrate Phosphoenolpyruvate and the Antibiotic Fosfomycin† | Q57978316 | ||
Role of the Ortholog and Paralog Amino Acid Invariants in the Active Site of the UDP-MurNAc-l-alanine:d-glutamate Ligase (MurD)† | Q57998973 | ||
P433 | issue | 4 | |
P304 | page(s) | 295-336 | |
P577 | publication date | 2010-11-22 | |
P1433 | published in | Critical Reviews in Biotechnology | Q5186663 |
P1476 | title | Peptidoglycan biosynthesis machinery: a rich source of drug targets | |
P478 | volume | 31 |
Q36848574 | A Bacterial Cell Shape-Determining Inhibitor. |
Q40145092 | Biology, Mechanism, and Structure of Enzymes in the α-d-Phosphohexomutase Superfamily |
Q28482216 | Comparative genomics analysis of Mycobacterium ulcerans for the identification of putative essential genes and therapeutic candidates |
Q27670473 | Crystal Structure of Bacillus anthracis Phosphoglucosamine Mutase, an Enzyme in the Peptidoglycan Biosynthetic Pathway |
Q48022320 | Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB. |
Q34211597 | Iminosugar C-glycoside analogues of α-D-GlcNAc-1-phosphate: synthesis and bacterial transglycosylase inhibition |
Q38068475 | Multitarget ligands in antibacterial research: progress and opportunities |
Q38070410 | Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond |
Q26747275 | Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents |
Q48118090 | Natural Products at Work: Structural Insights into Inhibition of the Bacterial Membrane Protein MraY. |
Q51749254 | Peptide Epimerization Machineries Found in Microorganisms. |
Q92926869 | Phosphorylation-Dependent Effects on the Structural Flexibility of Phosphoglucosamine Mutase from Bacillus anthracis |
Q41855455 | Structural basis for morpheein-type allosteric regulation of Escherichia coli glucosamine-6-phosphate synthase: equilibrium between inactive hexamer and active dimer |
Q27678828 | Substrate Channel Flexibility in Pseudomonas aeruginosa MurB Accommodates Two Distinct Substrates |
Q52618206 | Towards new antibiotics targeting bacterial transglycosylase: Synthesis of a Lipid II analog as stable transition-state mimic inhibitor. |
Q38070780 | Viable screening targets related to the bacterial cell wall. |
Search more.